Immunovia AB Stock
Stocks
IMMNOV
SE0006091997
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
21:00:00 26/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.0718 SEK | -0.28% |
|
-10.36% | -68.37% |
| 10-05 | 23 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 10-05 | Immunovia no longer has any public short sellers | FW |
| Market Cap | 48.3M 4.85M 4.34M 4.01M 3.63M 6.8M 462M 6.91M 19.1M 241M 18.21M 17.82M 764M | P/E 2026 * |
-0.72x | P/E 2027 * | -1.8x |
|---|---|---|---|---|---|
| Enterprise Value | 13.3M 1.34M 1.19M 1.11M 1M 1.87M 127M 1.9M 5.26M 66.47M 5.01M 4.91M 210M | EV / Sales 2026 * |
4.16x | EV / Sales 2027 * | 1.06x |
| Free-Float |
90.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IMMNOV | Delayed | |
CBOE
| IMMNOs | Real-time | |
|
OTC Markets
| IMMV.F | Delayed | |
|
CBOE
| 0G8X | Real-time | |
|
Deutsche Boerse AG
| 1YR | Delayed | |
|
Boerse Muenchen
| 1YR | Real-time |
Last Transcript: Immunovia AB
| 1 day | -0.28% | ||
| 1 week | -10.36% | ||
| Current month | -22.80% | ||
| 1 month | -48.64% | ||
| 3 months | -58.97% | ||
| 6 months | -64.54% | ||
| Current year | -68.37% |
| 1 week | 0.07 |  | 0.08 |
| 1 month | 0.06 | | 0.15 |
| Current year | 0.06 | | 0.25 |
| 1 year | 0.06 | | 0.36 |
| 3 years | 0.06 | | 4.73 |
| 5 years | 0.06 | | 131.5 |
| 10 years | 0.06 | | 298.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | 53 | 29/04/2023 |
Lisa Ford
CTO | Chief Tech/Sci/R&D Officer | 55 | 29/04/2024 |
| Chief Tech/Sci/R&D Officer | 54 | 31/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 09/12/2016 | |
Peter Andersen
CHM | Chairman | 70 | 26/05/2023 |
| Director/Board Member | 51 | 01/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/11/22 | Buy | Chief Executive Officer | 150,000 | 0.6628% | ||
| 24/05/22 | Buy | Chief Executive Officer | 100,000 | 0.4419% | ||
| 21/05/22 | Buy | Chief Executive Officer | 100,000 | 0.4419% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.28% | -10.36% | -77.91% | -86.95% | 4.88M | |
| +1.64% | +0.81% | +19.63% | +55.60% | 249B | |
| +1.07% | +3.81% | +4.47% | +20.29% | 162B | |
| -0.15% | +4.26% | -17.36% | +74.03% | 157B | |
| -0.24% | +1.18% | -54.92% | -8.44% | 66.22B | |
| -1.50% | +0.44% | +8.59% | +67.34% | 52.3B | |
| +1.03% | +3.07% | -14.62% | -8.28% | 52.18B | |
| +1.67% | +3.83% | +19.00% | +44.25% | 51.34B | |
| +1.67% | +3.57% | +18.87% | +68.69% | 48.79B | |
| +0.51% | +5.00% | +26.84% | +86.53% | 44.57B | |
| Average | +0.54% | +0.72% | -6.74% | +31.31% | 88.35B | |
| Weighted average by Cap. | +0.80% | +2.65% | +2.30% | +46.14% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.2M 321K 287K 266K 241K 451K 30.58M 458K 1.27M 16M 1.21M 1.18M 50.65M | 17.3M 1.74M 1.55M 1.44M 1.3M 2.44M 165M 2.48M 6.84M 86.47M 6.52M 6.38M 274M |
| Net income | -87M -8.74M -7.81M -7.23M -6.55M -12.25M -831M -12.45M -34.41M -435M -32.8M -32.1M -1.38B | -76M -7.63M -6.83M -6.32M -5.72M -10.7M -726M -10.88M -30.06M -380M -28.65M -28.04M -1.2B |
| Net Debt | -35M -3.52M -3.14M -2.91M -2.63M -4.93M -334M -5.01M -13.84M -175M -13.2M -12.91M -554M | -30M -3.01M -2.69M -2.49M -2.26M -4.22M -287M -4.29M -11.87M -150M -11.31M -11.07M -475M |
Employees
18
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/10/26 | SEK 0.0718 | -0.28% | 2,436,243 |
| 23/10/26 | SEK 0.0720 | -1.37% | 2,473,256 |
| 22/10/26 | SEK 0.0730 | -5.19% | 1,245,333 |
| 21/10/26 | SEK 0.0770 | -7.89% | 9,843,855 |
| 20/10/26 | SEK 0.0836 | +4.37% | 621,806 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMMNOV Stock
Select your edition
All financial news and data tailored to specific country editions
